Sitemap
Update: July 26th, 2009
Sitemap of posts on Orshe.com
Posts
- Category: Wall Street Journal (continued)
- Monkey See, Monkey Yawn: Hard-Wired for Empathy
- Montana Supreme Court to Tackle Physician-Assisted Suicide
- More Bad News for Vytorin and Zetia?
- More Baucus Bill: Subsidies and a ‘Young Invincible’ Plan
- More Deadly Swine Flu? CDC Mixes H1N1, H5N1 Viruses in Tests
- More Medical Schools Beef Up Conflicts Policies
- More On Ghostwriting, Wyeth and Hormone Replacement Therapy
- More Opposition Forms to Government Insurance Option
- More Patients Got Radiation Overdoses in CT Scans
- More Patients Took Antidepressants & Antipsychotics Together
- More Research Links Cardiovascular Health to Alzheimer’s
- More Sales Rep Jobs Bite the Dust, This Time at Amylin
- More Than Year Later, New AMA Conflicts Policy Still in Works
- More Training for Soldiers, With Feeling
- Mossberg on Blood-Glucose Test: Tech Meets Health
- Most Propofol Abusers are Medical Professionals
- MRI Inventor Refutes Lawmakers’ Calls to Cut Costly Scans
- Multaq Approval Marks Comeback for Sanofi’s Heart Drug
- Music Triggering Memories in Dementia Patients
- Mylan Says It’s in the Clear With FDA. FDA Disagrees.
- Myths Persist in Health-Care Debate
- N.Y. Govenor Pushes to Ban Drug-Industry Gifts to Docs
- N.Y.S. Health Commish Urges ‘Nada’ Marketing to Kids
- Navigating Health Food Claims
- Need a Swine-Flu Shot? Try Germany.
- Nestle Recalls Cookie Dough After FDA Issues Illness Warning
- Nestlé Said No to FDA Inspectors in Past
- New 3-D Biopsy Procedure for Prostate
- New Ad Takes Aim at Health-Reform Proposals
- New Avandia Study Brings Good News, Critics for Glaxo
- New Blood Thinners Could Be Alternatives to Coumadin, Plavix
- New Blood Thinners in the Spotlight at Heart Meeting
- New Cancer Drugs: Most Not Worth the Cost?
- New Cost Estimate for Baucus Bill Arrives Already (Lower!)
- New Diabetes-Drug Rival Could Be a Promising Sign for Amylin
- New Direction On Health-Care Reform
- New Direction On Healthcare Reform
- New FDA Boss Plans Changes
- New Fix for Fibroids
- New Health Proposal Could Help Consumers
- New Health-Reform Timetable: ‘Done By the Fall’
- New Merck Management: A Lot Like the Old Merck Management
- New Novartis CEO: Cafepharma Reader, Former Heinz Exec
- New Online Doctor Rating Site Treads Carefully
- New Pharma Guidelines: No Ghostwriting, More Public Info
- New Rules Could Further Expand Stem-Cell Research
- New Side Gig for Pfizer CEO: Director of New York Fed
- New Swine Flu Guidelines for Employers
- New Treatment for Blindness
- New York Closes More Schools as Assistant Principal Dies from Flu
- New York Ends Flu Shot Mandate for Health Care Workers
- Newly Uninsured Turn To Community Health Centers
- News Hub Extra: A Public Option Compromise
- News Hub: A Genetic Test for Weight Loss?
- News Hub: A Progress Report on the Health Bill
- News Hub: Autism Rates Found Higher in Some Areas
- News Hub: Big Week for Democrats
- News Hub: Clamping Down on Insurance Executive Pay
- News Hub: Details, Price Emerge on Health Bill
- News Hub: Even Thin People Face Health Risks
- News Hub: Evidence of Coffee's Health Benefits
- News Hub: Haiti Health-Care Chaos
- News Hub: Health-Care Debate Moves to Senate Floor
- News Hub: Howard Dean Leads Health Bill Revolt
- News Hub: In Speech, Obama Says Jobs a Priority
- News Hub: Is Obamacare Deal Possible Now?
- News Hub: Key Vote on Health Bill
- News Hub: Lieberman Digs In on Health Debate
- News Hub: Making Sense of New Mammogram Guidelines
- News Hub: New Doubts About Daily Aspirin Use
- News Hub: Novartis 'Squeezes' Alcon Shareholders
- News Hub: Plastic Surgery Demand Sags
- News Hub: Prospects for Obama's Health Proposal
- News Hub: Public Option Back From the Dead
- News Hub: Republicans Plan to Skewer Health Bill

